Bafna Pharmaceuticals Ltd.
BAFNAPH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.89B
Close$
$-67.54
115.9% downside
Current Fair Value
115.9% downsideOvervalued by 115.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.89 Billion |
|---|---|
| Enterprise Value | $9.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.69 |
| Beta | 0.08 |
| Outstanding Shares | 25,033,333 |
Return
| Return on Equity | 8.10% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 127.05 |
|---|---|
| PEG | -129.93 |
| Price to Sales | 7.46 |
| Price to Book Ratio | 11.18 |
| Enterprise Value to Revenue | 6.84 |
| Enterprise Value to EBIT | 97.62 |
| Enterprise Value to Net Income | 127 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bafna Pharmaceuticals Ltd.
339 employees
CEO: Bansilal Mahaveer Chand Bafna Bafna Pharmaceuticals Ltd. specializes in the production and distribution of finished pharmaceutical drugs within India. The company also maintains a significant international presence, exporting its medicinal products to a broad range o...